دورية أكاديمية
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases.
| العنوان: | Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases. |
|---|---|
| المؤلفون: | Zarubova J; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, CA 90095, USA., Zhang X; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, CA 90095, USA., Hoffman T; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, CA 90095, USA., Hasani-Sadrabadi MM; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, CA 90095, USA., Li S; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, CA 90095, USA.; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. |
| المصدر: | Matter [Matter] 2021 May 05; Vol. 4 (5), pp. 1528-1554. Date of Electronic Publication: 2021 Mar 09. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Cell Press Country of Publication: United States NLM ID: 101749591 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-2385 (Electronic) Linking ISSN: 25902385 NLM ISO Abbreviation: Matter Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Cambridge, MA : Cell Press |
| مستخلص: | Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, enhanced immunity, and other desirable functions to coordinate appropriate immune responses and to repair tissues. Based on the understanding of COVID-19 disease progression and immune responses to SARS-CoV-2, we discuss possible immunotherapeutic strategies and highlight biomaterial approaches from the perspectives of preventive immunization, therapeutic immunomodulation, and tissue healing and regeneration. Successful development of biomaterial platforms for immunization and immunomodulation will not only benefit COVID-19 patients, but also have broad applications for a variety of infectious diseases. Competing Interests: The authors declare no competing interests. (© 2021 Elsevier Inc.) |
| References: | Vaccine. 2015 Feb 11;33(7):861-8. (PMID: 25559188) Curr Top Microbiol Immunol. 2009;333:369-93. (PMID: 19768415) Front Cardiovasc Med. 2019 Mar 21;6:26. (PMID: 30949485) Sci Transl Med. 2019 Sep 25;11(511):. (PMID: 31554736) Nat Nanotechnol. 2020 Aug;15(8):716-723. (PMID: 32601450) ACS Biomater Sci Eng. 2020 Feb 10;6(2):759-778. (PMID: 33313391) Cell Rep. 2013 Oct 31;5(2):323-30. (PMID: 24120862) Immunity. 2020 Jun 16;52(6):905-909. (PMID: 32497522) Front Neurol. 2020 Apr 17;11:308. (PMID: 32362868) Curr Probl Cardiol. 2020 Aug;45(8):100618. (PMID: 32439197) Stem Cell Res Ther. 2016 Apr 23;7(1):63. (PMID: 27107963) J Control Release. 2014 Mar 10;177:34-41. (PMID: 24412573) EBioMedicine. 2020 May;55:102743. (PMID: 32249203) Sci Adv. 2019 Nov 13;5(11):eaax9250. (PMID: 31763454) NPJ Vaccines. 2018 Oct 10;3:51. (PMID: 30323958) Nat Rev Immunol. 2019 Sep;19(9):573-583. (PMID: 31186548) JAMA Cardiol. 2020 Nov 01;5(11):1265-1273. (PMID: 32730619) Adv Drug Deliv Rev. 2019 Nov - Dec;151-152:169-190. (PMID: 31071378) Autoimmun Rev. 2020 Jul;19(7):102569. (PMID: 32376394) Vaccine. 2013 Jul 18;31(33):3363-9. (PMID: 23684834) Heart Rhythm. 2020 Nov;17(11):1984-1990. (PMID: 32599178) Adv Sci (Weinh). 2017 Nov 09;5(1):1700426. (PMID: 29375970) Sci Transl Med. 2017 Jun 7;9(393):. (PMID: 28592561) Lancet Haematol. 2020 Aug;7(8):e575-e582. (PMID: 32619411) Int J Mol Sci. 2020 Mar 27;21(7):. (PMID: 32230828) J Infect. 2020 Jul;81(1):e33-e39. (PMID: 32294504) Front Genet. 2020 Jun 09;11:641. (PMID: 32582303) ACS Nano. 2017 Nov 28;11(11):10797-10807. (PMID: 29028303) Nat Nanotechnol. 2022 Jan;17(1):86-97. (PMID: 34795440) Expert Rev Vaccines. 2017 Jan;16(1):55-63. (PMID: 27448771) ACS Nano. 2013 Dec 23;7(12):11129-37. (PMID: 24182189) Nanomedicine. 2015 Jul;11(5):1189-99. (PMID: 25659645) ACS Nano. 2017 Jun 27;11(6):6194-6203. (PMID: 28481519) Lancet. 2020 May 2;395(10234):1417-1418. (PMID: 32325026) Lancet. 2017 Aug 12;390(10095):649-658. (PMID: 28666680) Nano Today. 2021 Feb;36:101019. (PMID: 33178330) Lancet Respir Med. 2020 Aug;8(8):807-815. (PMID: 32422178) Inflammation. 2019 Jun;42(3):953-960. (PMID: 30604194) Annu Rev Immunol. 2020 Apr 26;38:123-145. (PMID: 32045313) Bone Res. 2020 Feb 14;8:8. (PMID: 32128276) Nat Commun. 2018 Jul 11;9(1):2684. (PMID: 29992966) Sci Transl Med. 2018 Jan 17;10(424):. (PMID: 29343624) Nat Biotechnol. 2018 Feb;36(2):160-169. (PMID: 29334370) Immunol Rev. 2002 Oct;188:147-54. (PMID: 12445288) Nat Rev Drug Discov. 2015 Nov;14(11):781-803. (PMID: 26471369) Science. 1995 Sep 15;269(5230):1585-8. (PMID: 7545313) Med Microbiol Immunol. 2008 Mar;197(1):1-8. (PMID: 17638015) Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17727-17736. (PMID: 32665441) PLoS Biol. 2022 Nov 3;20(11):e3001845. (PMID: 36327326) Lancet Respir Med. 2020 Aug;8(8):750-752. (PMID: 32422177) Sci Rep. 2017 May 3;7(1):1407. (PMID: 28469272) Front Neurol. 2020 Jun 23;11:715. (PMID: 32655490) Biomaterials. 2015 Dec;72:138-51. (PMID: 26370927) Nat Neurosci. 2013 Sep;16(9):1211-1218. (PMID: 23872599) Heart Rhythm. 2020 Sep;17(9):1463-1471. (PMID: 32387246) Circulation. 2006 Oct 3;114(14):1504-11. (PMID: 17000904) Cell. 2020 May 28;181(5):1016-1035.e19. (PMID: 32413319) Cell. 2020 Oct 1;183(1):143-157.e13. (PMID: 32877699) Adv Exp Med Biol. 2017;1003:187-221. (PMID: 28667560) Nat Biomed Eng. 2018 May;2(5):304-317. (PMID: 30936449) J Infect. 2020 Sep;81(3):e41-e43. (PMID: 32603675) Nat Rev Immunol. 2020 Sep;20(9):529-536. (PMID: 32728222) Nat Med. 2020 Nov;26(11):1691-1693. (PMID: 32929268) Biomaterials. 2020 Sep;252:120058. (PMID: 32413594) Sci Transl Med. 2015 Jun 10;7(291):291ra94. (PMID: 26062846) Sci Adv. 2020 Oct 9;6(41):. (PMID: 33036973) JCI Insight. 2018 Jun 7;3(11):. (PMID: 29875326) Nature. 2017 Jun 22;546(7659):498-503. (PMID: 28607485) J Control Release. 2012 Oct 10;163(1):10-7. (PMID: 22776291) Biomaterials. 2021 Jan;266:120469. (PMID: 33120200) Sci Adv. 2020 Aug 07;6(32):eaba0995. (PMID: 32821819) Biomaterials. 2014 May;35(15):4477-88. (PMID: 24589361) J Cell Commun Signal. 2017 Jun;11(2):191-192. (PMID: 28493107) NPJ Regen Med. 2017 Jun 19;2:19. (PMID: 29302355) Travel Med Infect Dis. 2020 Jul - Aug;36:101642. (PMID: 32220634) Nat Commun. 2020 Jun 3;11(1):2795. (PMID: 32493933) Nanomedicine (Lond). 2015;10(23):3431-49. (PMID: 26607456) Nat Rev Drug Discov. 2020 May;19(5):305-306. (PMID: 32273591) Nanomicro Lett. 2020 Apr 20;12(1):96. (PMID: 34138079) Am J Public Health. 2021 Mar;111(3):355-358. (PMID: 33237801) Biomaterials. 2013 Jun;34(17):4339-46. (PMID: 23478034) Nature. 2014 Mar 27;507(7493):519-22. (PMID: 24531764) ACS Nano. 2020 Oct 27;14(10):12522-12537. (PMID: 33034449) Sci Transl Med. 2013 Sep 25;5(204):204ra130. (PMID: 24068737) Immunol Lett. 2012 Sep;147(1-2):55-62. (PMID: 22732235) EMBO J. 2018 Jul 2;37(13):. (PMID: 29866703) Adv Healthc Mater. 2014 Nov;3(11):1898-908. (PMID: 24923735) Cell. 2018 Nov 1;175(4):1059-1073.e21. (PMID: 30270039) JAMA. 2020 Aug 11;324(6):603-605. (PMID: 32644129) Sci Rep. 2019 Jul 11;9(1):10041. (PMID: 31296886) Acta Pharm Sin B. 2018 Jan;8(1):23-33. (PMID: 29872620) J Clin Med. 2020 Jun 19;9(6):. (PMID: 32575380) J Clin Invest. 2011 Jun;121(6):2065-73. (PMID: 21633173) Trends Pharmacol Sci. 2018 Jun;39(6):573-585. (PMID: 29655658) Nat Biomed Eng. 2020 Jun;4(6):636-648. (PMID: 32483299) Science. 2014 Feb 21;343(6173):885-8. (PMID: 24558160) Nat Rev Mater. 2020;5(11):847-860. (PMID: 33078077) Psychiatry Investig. 2019 Jan;16(1):59-64. (PMID: 30605995) Circ Res. 2017 May 26;120(11):1768-1775. (PMID: 28298296) ACS Biomater Sci Eng. 2019 May 13;5(5):2417-2429. (PMID: 33405750) Nat Rev Immunol. 2020 Jun;20(6):355-362. (PMID: 32376901) Sci Adv. 2020 May 27;6(22):eaba3167. (PMID: 32518825) Adv Mater. 2017 Apr;29(16):. (PMID: 28199033) Nat Commun. 2020 Feb 28;11(1):1110. (PMID: 32111828) Respirology. 2010 Apr;15(3):543-50. (PMID: 20337995) Biomolecules. 2018 Nov 14;8(4):. (PMID: 30441852) Sci Adv. 2021 Feb 5;7(6):. (PMID: 33547083) Nature. 2015 Oct 1;526(7571):118-21. (PMID: 26374997) Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4. (PMID: 16549762) Adv Mater. 2018 Feb;30(7):. (PMID: 29315824) Mol Pharm. 2019 Dec 2;16(12):5000-5012. (PMID: 31621331) Science. 2019 Feb 8;363(6427):649-654. (PMID: 30573546) Adv Mater. 2019 May;31(19):e1901179. (PMID: 30924234) Nat Nanotechnol. 2014 Mar;9(3):204-10. (PMID: 24561355) J Control Release. 2012 Feb 10;157(3):354-65. (PMID: 21820024) N Engl J Med. 2020 Dec 10;383(24):2320-2332. (PMID: 32877576) J Thorac Imaging. 2020 Jul;35(4):W87-W89. (PMID: 32404798) Nat Nanotechnol. 2020 Jun;15(6):491-499. (PMID: 32523099) Blood Cells Mol Dis. 2005 Sep-Oct;35(2):158-68. (PMID: 16087368) Front Immunol. 2018 Oct 08;9:2303. (PMID: 30349538) ACS Omega. 2018 Sep 30;3(9):11993-12009. (PMID: 30320284) Front Bioeng Biotechnol. 2020 Apr 07;8:292. (PMID: 32318563) Immunity. 2016 Mar 15;44(3):597-608. (PMID: 26944200) ACS Nano. 2017 Feb 28;11(2):1397-1411. (PMID: 28075552) EClinicalMedicine. 2020 Nov;28:100590. (PMID: 33173853) J Control Release. 2016 Feb 28;224:208-216. (PMID: 26778696) EMBO Mol Med. 2020 Aug 7;12(8):e12642. (PMID: 32559343) Adv Mater. 2015 Oct 7;27(37):5547-52. (PMID: 26305446) Thromb Res. 2020 Jul;191:145-147. (PMID: 32291094) Expert Rev Respir Med. 2020 Sep;14(9):865-868. (PMID: 32567404) J Thromb Haemost. 2020 Aug;18(8):1859-1865. (PMID: 32459046) Sci Adv. 2019 Jul 31;5(7):eaav6313. (PMID: 31392268) Front Immunol. 2020 Jun 16;11:1445. (PMID: 32612616) Adv Mater. 2018 Jun;30(23):e1706780. (PMID: 29682803) Biomaterials. 2019 May;203:52-62. (PMID: 30852423) J Control Release. 2015 May 10;205:35-44. (PMID: 25483424) Nature. 2009 Nov 26;462(7272):449-60. (PMID: 19940915) Immunobiology. 2020 Nov;225(6):152001. (PMID: 32943233) Lancet Haematol. 2020 Jun;7(6):e438-e440. (PMID: 32407672) J Mol Cell Cardiol. 2017 Feb;103:22-30. (PMID: 28041873) Stem Cell Rev Rep. 2020 Jun;16(3):427-433. (PMID: 32281052) Vaccine. 2015 Nov 4;33(44):5920-6. (PMID: 26407920) Virus Res. 2020 Oct 15;288:198082. (PMID: 32621841) J Control Release. 2015 Feb 10;199:29-36. (PMID: 25481443) Bioconjug Chem. 2008 Jan;19(1):145-52. (PMID: 17997512) Front Immunol. 2019 Jan 22;10:8. (PMID: 30723469) Radiology. 2020 Aug;296(2):E55-E64. (PMID: 32191587) Cytokine Growth Factor Rev. 2014 Aug;25(4):369-76. (PMID: 25156421) Chem Rev. 2015 Oct 14;115(19):11109-46. (PMID: 26154342) Sci Transl Med. 2012 Aug 22;4(148):148rv9. (PMID: 22914624) ACS Appl Mater Interfaces. 2019 May 8;11(18):16380-16390. (PMID: 30973702) J Exp Med. 2020 Aug 3;217(8):. (PMID: 32484502) ACS Nano. 2015 Dec 22;9(12):11800-11. (PMID: 26516654) Mol Immunol. 2014 Oct;61(2):69-78. (PMID: 24935208) Nat Mater. 2011 Mar;10(3):243-51. (PMID: 21336265) Biomaterials. 2015 Jul;56:78-85. (PMID: 25934281) Nat Rev Immunol. 2020 Jun;20(6):363-374. (PMID: 32346093) Signal Transduct Target Ther. 2022 Sep 14;7(1):318. (PMID: 36100602) Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15392-15397. (PMID: 31311862) Expert Rev Vaccines. 2011 Apr;10(4):523-37. (PMID: 21506649) Front Immunol. 2018 May 17;9:1093. (PMID: 29868035) PLoS One. 2007 Jul 18;2(7):e623. (PMID: 17637839) Eur Respir Rev. 2015 Jun;24(136):356-60. (PMID: 26028646) Neurologia (Engl Ed). 2020 May;35(4):245-251. (PMID: 32364119) BMC Neurol. 2011 Mar 24;11:37. (PMID: 21435231) J Exp Med. 2020 Jun 1;217(6):. (PMID: 32302401) iScience. 2020 Mar 27;23(3):100867. (PMID: 32105634) Thromb Res. 2020 Oct;194:101-115. (PMID: 32788101) Curr Opin Immunol. 2020 Aug;65:1-6. (PMID: 32200132) Nat Rev Cardiol. 2020 Sep;17(9):543-558. (PMID: 32690910) Vaccines (Basel). 2020 Mar 13;8(1):. (PMID: 32183209) Immunol Rev. 2011 Jan;239(1):178-96. (PMID: 21198672) Ernst Schering Res Found Workshop. 2006;(55):197-218. (PMID: 16329664) Science. 1993 Nov 26;262(5138):1448-51. (PMID: 8248784) Vaccine. 2016 Apr 7;34(16):1927-35. (PMID: 26921779) Biotechnol Rep (Amst). 2020 Jul 06;27:e00494. (PMID: 32714852) |
| معلومات مُعتمدة: | R56 DE029157 United States DE NIDCR NIH HHS |
| فهرسة مساهمة: | Keywords: drug delivery; immunomodulation; tissue regeneration; vaccine |
| تواريخ الأحداث: | Date Created: 20210316 Latest Revision: 20221222 |
| رمز التحديث: | 20221222 |
| مُعرف محوري في PubMed: | PMC7942141 |
| DOI: | 10.1016/j.matt.2021.02.025 |
| PMID: | 33723531 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2590-2385 |
|---|---|
| DOI: | 10.1016/j.matt.2021.02.025 |